Recently, we reported that expression of the v-erbB oncogene, the ligand-independent variant of epidermal growth factor receptor (EGF-R), in bone marrow (BM)-reconstituted mice leads to the development of a severe mast cell disease reminiscent of malignant mastocytosis.' Primary recipients showed massive infiltration of CTMCs in BM, spleen, and other visceral organs. In addition to its effect on mast cell (MC) development, v-erbB affects various other lineages of the mouse hematopoietic system. Expression induces early erythroid progenitors to factor-independent growth and differentiation6 and leads to the transformation of B-cell progenitor^',^ and of early myeloid precursor cells.' In addition, retroviral transfer ofthe complete human EGF-R (HERc) in mouse BM cells (BMCs) leads to the outgrowth of EGF-dependent BM mast cells (BMMCs) when cultivated in the presence of interleukin-3 (IL-3) and EGF.' Finally, EGF induces mast cell differentiation of a pre-mast cell line ectopically expressing human EGF-R." In contrast, EGF had no effect on the proliferation of BMC-derived macrophages or T-and B-cell lines ectopically expressing EGF-R.'1,12 These experiments suggest that MCs may be specifi- 
cally susceptible to mitogenic signals transduced by normal and mutant EGF-Rs. However, there is no evidence of functional EGF or transforming growth factor a (TGF-a) receptor expression during normal mammalian hematopoiesis, although one cannot exclude the possibility that this, or a related receptor, may be expressed on a minor currently unidentified population of BMCs. We suggested earlier that v-erbB probably uses signal transduction pathways associated with the SLF-R,5 based on the observation that all murine lineages affected by v-erbB express SLF-R and are responsive to its ligand.
To test our hypothesis directly, we analyzed the capacity of normal and mutant EGF-Rs to complement the function of the SLF-R in BMMC differentiation taking advantage of W / W mutant mice. IL-3-derived BMMCs resemble mucosal MCs (MMCs), that are characterized by a relatively low electron density of the granules, low histamine content, and the production ofchondroitin sulfate E. They stain positive with Giemsa, toluidine blue, and alcian blue but not with safranin or berberine sulfate, which is diagnostic for CTMCs.I3sL4 Long-term cultivation of normal BMMCs in medium containing SLF induces safranin-positive and berberine sulfate-positive staining, which has been shown to correlate well with the ability of these cells to synthesize heparin p r o t e o g l y c a n~, '~~~~ the predominant proteoglycan in CTMCS.'~,'~ BMMCs carrying W mutations can be readily derived in vitro in the presence of IL-3, but because of the lack of functional SLF-R, they fail to proliferate in response to SLF and are incapable of differentiating into CTMCs." Retroviral transfer of functional SLF-R rescues the W-associated MC defects and restores their ability to grow and to differentiate in response to SLF.18 If EGF-R and v-erbB signal transduction in mouse hematopoietic cells, especially in the MC lineage, involves a SLF-R-associated pathway, one would predict that ectopic expression of these receptors in W / W BMMCs would also restore their ability to differentiate into CTMCs. Here we show that retrovirus-mediated transfer of HERc, a chimeric EGF-R/v-erbB receptor (HERerbB), and the v-erbB oncogene partially compensates for the missing signal transduction of the SLF-R in W / W BMMCs and enables their differentiation into CTMC-like cells in vitro and in vivo.
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MATERIALS AND METHODS
Retroviral vectors expressing the normal human (HERc) and mutant EGF-Rs (HERerbB and v-erbB) are based on the NTK ~ector.'.'~ NTK-HERc was generated by inserting a 3.9-kb Xhol fragment derived from pXTKHERc9 into the Xhol site. The HERerhB cDNA coding for the ligand-binding and transmembrane domain of HERc (residues -24 to 646)20 and the intracellular domain of v-crhB (AEV-ES4 strain) was inserted into the Clal site to generate NTK-HERerbB. NTK-VerhB was obtained by inserting a 1.7-kb Xhol-Clal fragment encoding the v-erbB oncogene (AEV-ES4 strain) into the Xhol and Clal sites as described previously.' The N2 retroviral vector has been described earlier.2'.22 Ecotropic virus stocks were prepared from the G P + E86 producer line2' as described before.'s9 The titers of the recombinant viruses, ranging from I to 5 X IO6 G418 resistant colony-forming units (CFU) per milliliter, were determined by infecting NIH3T3 (TK-) cells ( IO' cells per 6-cm dish), followed by selection with G418 (GIBCO, Grand Island, NY, I mg/mL).
Cells and cell culture. All cell lines were maintained in Iscove's modified Dulbecco's medium (IMDM, GIBCO) supplemented with 10% fetal calf serum (FCS) . Primary mouse BMCs were cultivated in IMDM supplemented with 3% FCS, I mg/mL bovine serum albumin (BSA), 0.2 mg/mL transferrin, 2 pL/mL of a lipid cocktail (all Boehringer-Mannheim. Germany), I% 1L-3-conditioned media (CM), and 10% 5637 CM. IL-3 CM was obtained from the X63/OAg8-653 myeloma cell line transfected with a plasmid expressing the murine IL-3 cDNA?~ kindly provided by Drs Hajime Karasuyama and Fritz Melchers. Conditioned media of the 5637 human bladder carcinoma cell line (5637 CM) served as a source of IL-I and a variety of other factors and was used as described.2' Recombinant human EGF was purchased from Boehringer-Mann heim.
BMC inficfion. BMCs obtained from 8-to 12-week-old male W / W and WB/C57 mice that had been injected 5 days earlier with 5-fluorouracil (5-FU; 150 mg/kg, Sigma Chemical Co, St Louis, MO), were infected with recombinant retroviruses essentially as described previ~usly?'.~' Briefly, BMCs were harvested from femurs and tibias and cultured in virus-containing supernatants derived from the packagingcell linessupplemented with I% IL-3 CM, 15% 5637 CM, and polybrene (5 pg/mL) for 18 to 24 hours. Infected BMCs were selected in medium containing I mg/mL G4 18. Flow cyfomerric anal-vsis. Cells were washed twice with phosphate buffered saline (PBS) supplemented with I% FCS and 0.05% sodium azide (wash buffer) before incubating for 30 minutes with the mouse monoclonal antibody (MoAb) RIZ6 that specifically recognizes the extracellular domain of the human EGF-R. Fluorescein-labeled F(ab'), fragments of goat-antimouse IgG (Dianova, Hamburg, Germany) were used as secondary antibody and viable cells were analyzed using a Becton-Dickinson (Mountain View, CA) FACScan analyzer.
Scarchard hlot analjais. Cells were washed three times in PBS and incubated with various concentrations of '251-EGF ( I 333 Ci/ mmol, Amerham [Arlington Heights, IL], IM96). The reaction was performed in triplicates in 100 pL PBS plus I% FCS with 3 to 5 X IO5 cells at 4°C for 4 hours under constant agitation. To remove unbound EGF, cells were spun through ice-cold FCSand then resuspended in 100 pL ice-cold PBS. Bound radioactivity was counted using a gamma counter. The specificity of the binding was confirmed by the addition of excess unlabeled EGF.
['Hlfhymidine incorporation. Cells were washed three times in PBS before plating into 96-well dishes at IO4 cells per well. Triplicate cultures were established for each concentration of IL-3 or EGF. After 24 to 48 hours [3H]thymidine ( I pCi/well) was added and incubation continued for 2 to 4 hours. Cells were harvested Generation of recomhinanr retrovirirses.
onto glass-fiber filters and the radioactivity incorporated into the DNA was measured by liquid scintillation counting.
RESULTS
Expression of normal human and mutant EGF-Rs on W/wY BMC. Retroviral vectors were used to efficiently express the normal human EGF receptor (NTK-HERc): a chimeric EGF-R/v-erbB receptor (NTK-HERerbB), and the v-erbB oncogene (NTK-v-erbB).' All vectors express the growth factor receptor cDNAs under control of an internal thymidine kinase (TK) promoter and the selectable neomycin (NEO) resistance gene driven by the 5' long terminal repeat (LTR) (Fig 1) . As a control, the N2 retroviral vector (Fig 1) For personal use only. on October 30, 2017. by guest www.bloodjournal.org From
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resulted in almost identical levels of HERc or HERerbB cell surface expression as determined by flow cytometric analysis (Fig 2A) and Scatchard blot analysis (Fig 2B) . The latter method showed 4,200 high-affinity HERc and 3,300 highaffinity HERerbB binding sites ( Fig 2B) per cell, which is consistent with the HERc expression levels observed earlier on normal BMCs infected with NTK-HERc.~ In cells infected with NTK-v-erbB, no expression of the v-erbB protein could be detected with either method, because BMC/ v-erbB do not express the EGF binding domain. However, the ability of the NTK-v-erbB vector to express functional v-erbB protein in infected and G418 selected BMCs has been previously shown. 5 Mitogenic signal transduction of HERc, HERerbB, and v-erbB on W/Wv BMCs. To determine the transduction of mitogenic signals by the ectopically expressed receptors on v-erbB IL-3-dependent BMC proliferation, infected cells were plated in a short-term proliferation assay and the rate of de novo DNA synthesis was determined by measuring the uptake of tritiated thymidine. Infected cells were maintained under IL-3 saturation conditions in the absence or presence of EGF, because previous observations had indicated that cultivation of wild-type BMCs expressing HERc in the presence of EGF leads to an outgrowth of EGF-dependent cells.' In the absence of EGF, BMC/HERc and BMCIHERerbB, previously maintained without EGF, showed no difference in the rate of IL-3-dependent DNA synthesis as compared with the N2-infected (BMC/N2) control cells, whereas BMC/v-erbB showed a strong increase in DNA synthesis (Fig 3A) . In the presence of EGF, DNA synthesis significantly increased in BMC/HERc and BMCIHERerbB but still did not reach levels seen in BMC/v-erbB (Fig 3B) . The synergistic effect of EGF on IL-3-dependent proliferation was most evident when cells were grown in limiting IL-3 concentrations. In the absence of IL-3, no significant thymidine uptake was observed. The effect of EGF on DNA synthesis was next determined on cells that were maintained in the presence of EGF for at least 2 weeks. Although the rate of DNA synthesis in BMC/v-erbB was not affected by the different culture conditions (Fig 3A,C) , BMC/HERc and BMCIHERerbB appeared to be less responsive to low levels of IL-3 in the absence of EGF as compared with BMC/N2 (Fig 3C) or as compared with BMC/HERc and BMC/HERerbB previously maintained without IL-3 ( Fig 3A) . However, in the presence EGF, DNA synthesis of BMC/HERc and BMCIHERerbB was drastically enhanced, reaching the same level as BMC/v-erbB (Fig 3D) . These findings confirm our previous observation that activation of the ectopically expressed receptors selects for EGF-responsive cells. Interestingly, this assay did not detect any differences in the capacity of normal and mutant EGF-Rs to stimulate DNA synthesis nor the residual EGF-independent activity of HERerbB.
To assess whether this difference when compared with our results obtained in the focus formation assay is cell type specific or caused by the different assay conditions, a longterm proliferation assay was performed with the infected W / W BMCs. In the absence of exogenous EGF, BMC/ HERc grew at the same rate as the control cells, whereas BMCIHERerbB proliferated significantly faster, although less vigorously, than BMC/v-erbB (Fig 4A) . These results show that both mutant receptors retain their EGF-independent activity on primary BMCs. In the presence of EGF, a strong stimulation of cell proliferation was observed for both BMC/HERc and BMCIHERerbB, whereas BMC/N2 and BMC/v-erbB failed to response to this ligand (Fig 4B) . Remarkably, in this long-term proliferation assay, BMC/ HERc and BMCIHERerbB grew even faster than BMC/verbB. However, after 3 to 4 weeks in culture, the proliferation rate of BMC/v-erbB increased steadily (not shown), which suggests a continuous selection for rapidly growing cells.
To determine whether the mutant receptors could substitute the IL-3-dependent mitogenic signal required for proliferation of the infected W / W BMCs, we tested their EGF- 
IL-3 CM ("/O,
dependent growth-stimulation capacity in the absence of IL-3. BMC/N2 control cells and BMCfHERc deteriorated within few days after withdrawal of IL-3, whereas BMC/ HERerbB and BMC/v-erbB remained viable for more than a week (Fig 4C) . Nevertheless, in these cultures, the cell numbers also declined steadily and the cells finally senesced (not shown). These results indicate that on primary W / W BMCs, the mutant receptors transduce stronger or additional mitogenic signals when compared with the normal EGF-R, which, however, do not suffice to maintain longterm proliferation. SA, arrows). This observation was confirmed by toluidine blue-positive staining (not shown) suggesting a heterogeneity in these cultures. To determine whether this merely reflects different stages of MMC maturation or, alternatively, whether a subpopulation of cells had differentiated, cytospin preparations were stained with alcian blue and safranin (Fig SB) . About 30% to 40% of the BMMC/HERc and BMMCIHERerbB but not the control BMMC/N2 showed strong safranin staining (safranin positive) of several granules and many of them contained only safranin-positive granules (Fig 5B, inserts) . In the absence of EGF, no safranin-positive BMMC/HERc (not shown) and only few &-nin-positive BMMCIHERerbB were detected (Fig SC) . The proportion of safranin-positive BMMCIHERerbB and the intensity of their staining increased significantly when EGF was added to these cultures for 5 days (Fig 5C) . Withdrawal of IL-3 and cultivation only in the presence of EGF increased the proportion of safranin-positive cells up to 90%. Also, the intensity of the staining was strongest under these conditions. However, the safranin-positive cells did not stain positive with berberine sulfate, which may reflect a still incomplete differentiation. Nonetheless, these findings show that ectopic expression of normal and mutant EGF-R in W / W BMMCs enables EGF-dependent CTMC differentiation and further indicate that IL-3 may have an adverse effect on BMMC differentiation.
W/Wv BMMCs expressing normal or mutant EGF-Rs survive and differentiate when injected into the peritoneal cavity of W/Wv mice. The W-associated MC defect is manifested in vivo by the total absence of mature CTMCs." However, IL-3-derived wild-type BMMCs" or W / W BMMCS" ectopically expressing functional SLF-R persist and differentiate when injected into the peritoneal cavity of W / W mice. To determine whether expression of normal and mutant EGF-Rs could also restore the W-associated mast cell defect in vivo, the ability of the infected BMMCs to colonize the peritoneal cavity of W/WT mice was examined. Indeed, BMMCs expressing the foreign receptors could colonize the peritoneal cavity and differentiated into safranin-positive CTMCs (Table 1 ). In contrast, no mast cells could be recovered from BMMC/N2-injected mice, whereas wild-type (WB/C57) BMMCs infected with N2 survived and differentiated in vivo as expected ( Table 1) . Intraperitoneal survival and differentiation of BMMC/ HERc and BMMCIHERerbB was only observed when mitomycin C-treated fibroblasts secreting rTGF-a, which stimulates these receptors with the same efficiency as EGF (not shown), were co-injected. In culture, half-maximal proliferation of FDC-PI cells expressing HERerbB was observed in Table 1 the presence of 10% CM from 3T3/TGF-a cells that was not present in CM obtained from wild-type NIH3T3 cells (not shown). The efficiency of peritoneal colonization and CTMC differentiation of mutant BMMC/v-erbB was comparable with wild-type BMMCs (WB/C5 7-N2), whereas the frequencies of recovered MCs from mice injected with BMMC/HERc or BMMCIHERerbB were reduced to 40% and 44%, respectively. Also, the capacity of mitomycintreated TGF-a producer cells to maintain MC survival was drastically reduced after 3 weeks; most likely caused by death of the TGF-a-secreting cells. In contrast, BMC/ v-erbB were able to persist for more than 4 weeks and exhibited strong positive staining with berberine sulfate (not shown). (Staining with berberine sulfate at 2 weeks was weakly positive or negative.) Yet, the proportion of safranin-positive mutant MCs recovered after 2 weeks was similar to that observed for the recovered wild-type cells (Table  1) . About 40% of these cells were safranin positive, whereas the proportion of safranin-positive mutant MCs expressing normal and mutant EGF-Rs ranged from 28% to 58%. These results reinforce our in vitro data showing that ectopic expression of these receptors in W / W BMMCs is able to complement the genetic defects in MC development associated with missing SLF-R.
DISCUSSION
In this study, we describe the rescue of W-associated MC defects in W / W BMCs by ectopic expression of normal or mutant EGF-Rs. For efficient gene transfer, retroviral vectors transducing the complete human EGF-R (NTKHERc), a chimeric EGF-R/v-erbB receptor (NTK-HERerbB), and the v-erbB oncogene (NTK-v-erbB) were used.
After infection of W / W BMCs, equal levels of functional receptors could be shown on BMC/HERc and BMC/HERerbB that were in good agreement with earlier results obtained with wild-type BMC/HERc9 In the presence of IL-3, all three proteins transduced functional mitogenic signals leading to a stimulation of DNA synthesis and cell proliferation and confirming their functional activity also on W / W BMCs. The responsiveness of BMC/HERc and BMC/HERerbB to EGF was strongly increased when these cells were maintained in the presence of IL-3 and EGF. This result confirms our previous observation that stimulation of the ectopically expressed receptors leads to selection for EGFdependent cells'; however, EGF alone was not sufficient to maintain long-term proliferation. In contrast, BMC/HERerbB and BMC/v-erbB remained viable for 5 to 7 days in the absence of IL-3, but finally also these cells died. Retroviral transfer of colony stimulating factor (CSF)-1 R, which is closely related to the SLF-R, although failing to stimulate CSF-1 -dependent proliferation, has also been shown to sustain only survival of W / W BMMCs in a fibroblast coculture system.2g In contrast, ectopic expression of functional SLF-R in mutant BMMCs enables SLF-dependent proliferation in the absence of IL-3." These experiments show that both CSF-1 R and EGF-R transduce functional mitogenic signals in W / W BMMCs, although only partially compensating the missing SLF-R in stimulating cell proliferation. This could be caused by either insufficient levels of ectopic For personal use only. on October 30, 2017. by guest www.bloodjournal.org From receptor expression or to partial stimulation of the SLF-Rrelated signal transduction pathways.
In addition to their mitogenic effect, normal and mutant EGF-Rs also affected the IL-3-dependent differentiation of infected BMCs. Normally, cultivation of BMCs yields pure mast cell cultures (BMMCs) that resemble mucosal MCs by several cytologic and biochemical riter ria.'^,'^ Cytologic staining of BMMCs expressing the foreign receptors, however, showed that a large proportion had differentiated into safranin-positive CTMC-like cells, whereas the control cells remained safranin negative. The generation of safraninpositive BMMC/HERc and BMMCIHERerbB was EGF dependent, whereas BMMC/v-erbB also differentiated in the absence of EGF. Interestingly, IG3 had an adverse effect on CTMC differentiation. These results are in good agreement with recent reports showing that SLF-mediated in vitro differentiation of wild-type BMMCs to CTMCs is only partial.'5s'6 About 50% of such cells acquired a CTMC phenotype, whereas the remaining half showed a mixed or MMC phenotype as determined by alcian blue/safranin staining.I5 Interestingly, exposure to IL-3 and SLF simultaneously prevented SLF-mediated CTMC differentiation.I6 The inability of the IL-3/EGF-derived MCs to stain positive with berberine sulfate may be caused by incomplete maturation under these culture conditions. Serosal mast cells freshly isolated from the peritoneal cavity stain and strongly positive with safranin and berberine sulfate.'*.16 However, this staining is reduced in cultures supplemented with SLF" and lost completely in the presence of IL-3 (T. von Ruden, unpublished observation). The ability of the ectopically expressed receptors to induce CTMC differentiation and the competitive interaction of IL-3 suggests that both normal and mutant EGF-Rs may act in a manner very similar to SLF-R in BMMC differentiation.
In support of our in vitro results was the finding that ectopic expression of normal and mutant EGF-Rs on W/ W BMMCs also restored their capacity to survive and differentiate in vivo. As do wild-type BMMCs, infected mutant BMMCs colonized the peritoneal cavity of injected W / W recipients and differentiated into safranin-positive CTMC-like cells. Although the frequency of recovered BMMC/v-erbB was comparable with that of cultivated wild-type BMMCs (BMMC/N2), the numbers of mutant BMMC/HERc and BMMCIHERerbB were only about 40% of wild-type levels; most likely caused by inefficient stimulation of the ectopically expressed receptors. This assumption is based on the observation that mutant BMMCs expressing the ligand-independent v-erbB protein persisted and differentiated in vivo with similar efficiency as normal BMMCs. However, we cannot exclude the possibility that the oncogenic v-erbB acts slightly differently than the ligand-dependent chimeric HERerbB and the normal HERc receptors. In accordance with previous reports, intraperitoneal differentiation of the injected IL-3-derived BMMCs apparently did not lead to complete CTMC maturation as compared with serosal CTMCs recovered from wild-type mice. Such cells stain strongly safranin positive but do not stain with alcian b l~e . '~, '~ In contrast, injected wild-type BMMCs and also W / W BMMCs ectopically expressing SLF-R differentiate only partially into CTMCS.'~ In our present work, the proportion of safranin-positive cells recovered from mice injected with W / W BMMCs expressing the foreign receptors was also equivalent to the proportion of safranin-positive cells recovered from mice injected with wild-type BMMCs infected with a control virus.
In conclusion, our experiments show that expression of normal and mutant EGF-Rs in W / W BMMCs partially compensates the SLF-R-mediated mitogenesis and restores their capacity to differentiate in vitro and in vivo into safranin-positive CTMC-like cells. We show that ectopic expression of these receptors can complement the missing SLF-R function in MC development. These findings support our hypothesis that EGF-R and v-erbB use signal transduction pathways partially overlapping with SLF-R-associated pathways when expressed in hematopoietic cells. There is still no direct experimental evidence delineating at which step these signals merge; several molecules, such as phospholipase C-7 and phosphatidyl 3'4nositol kinase have been reported to be involved in both SLF-R and EGF-R signal transduction. In contrast to EGF-R, no binding of SLF-R to ras-guanosine triphosphatase-activating protein has been detected.*' These findings indicate that the signal transduction pathways of SLF-R and EGF-R, although apparently sharing several components, are not identical. This may also explain why ectopically expressed receptors only partially complement the mitogenic activity of the SLF-R, whereas the differentiation capacity seems to be completely restored. Finally, our experiments reinforce the hypothesis that different tyrosine kinase receptors may use overlapping signal transduction pathways and stress the important role of a regulated expression of growth factor/cytokine receptors in hematopoietic development.
